Among 138 patients, 38 patients were retreated with oral NAs due to virologic relapse or ALT elevation (≥2 x ULN) (Table2) and of these, 12 (31.6%) patients showed hepatitis flare (≥10 x ULN). This evidence concerns the gene GPT and hepatitis A virus infection.